NVOS Annual EBIT
-$8.15 M
+$17.35 M+68.03%
31 August 2023
Summary:
As of February 5, 2025, NVOS annual earnings before interest & taxes is -$8.15 million, with the most recent change of +$17.35 million (+68.03%) on August 31, 2023. During the last 3 years, it has fallen by -$3.38 million (-70.99%). NVOS annual EBIT is now -10231.81% below its all-time high of -$11.10 thousand.NVOS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVOS Quarterly EBIT
-$10.65 M
-$9.16 M-613.86%
31 May 2024
Summary:
As of February 5, 2025, NVOS quarterly earnings before interest & taxes is -$10.65 million, with the most recent change of -$9.16 million (-613.86%) on May 31, 2024. Over the past year, it has dropped by -$9.33 million (-707.23%). NVOS quarterly EBIT is now -6663.77% below its all-time high of $162.30 thousand, reached on August 31, 2019.NVOS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVOS TTM EBIT
-$18.30 M
-$9.33 M-104.10%
31 May 2024
Summary:
As of February 5, 2025, NVOS TTM earnings before interest & taxes is -$18.30 million, with the most recent change of -$9.33 million (-104.10%) on May 31, 2024. Over the past year, it has increased by +$7.61 million (+29.38%). NVOS TTM EBIT is now -92786.80% below its all-time high of -$19.70 thousand, reached on November 30, 2019.NVOS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVOS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +68.0% | -707.2% | +29.4% |
| 3 y3 years | -71.0% | -367.4% | +29.9% |
| 5 y5 years | -425.0% | -367.4% | +29.9% |
NVOS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.3% | +68.0% | -871.4% | +48.1% | -248.8% | +29.9% |
| 5 y | 5-year | -4393.8% | +68.0% | <-9999.0% | +48.1% | <-9999.0% | +29.9% |
| alltime | all time | <-9999.0% | +68.0% | -6663.8% | +48.1% | <-9999.0% | +29.9% |
Novo Integrated Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2024 | - | -$10.65 M(+613.9%) | -$18.30 M(+104.1%) |
| Feb 2024 | - | -$1.49 M(-56.6%) | -$8.97 M(-3.1%) |
| Nov 2023 | - | -$3.44 M(+26.9%) | -$9.25 M(+14.4%) |
| Aug 2023 | -$8.15 M(-68.0%) | -$2.71 M(+105.5%) | -$8.09 M(-68.8%) |
| May 2023 | - | -$1.32 M(-25.9%) | -$25.91 M(+0.9%) |
| Feb 2023 | - | -$1.78 M(-21.9%) | -$25.69 M(-1.5%) |
| Nov 2022 | - | -$2.28 M(-88.9%) | -$26.09 M(+2.3%) |
| Aug 2022 | -$25.50 M(+492.2%) | -$20.53 M(+1772.3%) | -$25.50 M(+274.4%) |
| May 2022 | - | -$1.10 M(-49.7%) | -$6.81 M(+11.5%) |
| Feb 2022 | - | -$2.18 M(+29.0%) | -$6.11 M(+16.4%) |
| Nov 2021 | - | -$1.69 M(-8.4%) | -$5.25 M(+21.8%) |
| Aug 2021 | -$4.31 M(-9.7%) | -$1.85 M(+368.9%) | -$4.31 M(-35.3%) |
| May 2021 | - | -$393.60 K(-70.1%) | -$6.66 M(+5.4%) |
| Feb 2021 | - | -$1.32 M(+75.9%) | -$6.32 M(+15.5%) |
| Nov 2020 | - | -$749.20 K(-82.2%) | -$5.47 M(+14.7%) |
| Aug 2020 | -$4.77 M(+2528.2%) | -$4.20 M(+7850.8%) | -$4.77 M(+1070.8%) |
| May 2020 | - | -$52.80 K(-88.7%) | -$407.20 K(-1.5%) |
| Feb 2020 | - | -$468.10 K(+863.2%) | -$413.40 K(+1998.5%) |
| Nov 2019 | - | -$48.60 K(-129.9%) | -$19.70 K(-89.1%) |
| Aug 2019 | -$181.40 K(-88.3%) | $162.30 K(-375.1%) | -$181.40 K(-56.9%) |
| May 2019 | - | -$59.00 K(-20.7%) | -$420.80 K(-21.9%) |
| Feb 2019 | - | -$74.40 K(-64.6%) | -$538.50 K(-66.1%) |
| Nov 2018 | - | -$210.30 K(+172.8%) | -$1.59 M(+2.4%) |
| Aug 2018 | -$1.55 M(+1867.9%) | -$77.10 K(-56.4%) | -$1.55 M(+8.2%) |
| May 2018 | - | -$176.70 K(-84.3%) | -$1.43 M(-5.0%) |
| Feb 2018 | - | -$1.13 M(+553.9%) | -$1.51 M(+259.4%) |
| Nov 2017 | - | -$172.30 K(-518.2%) | -$420.10 K(+44.7%) |
| Aug 2017 | -$78.90 K(-52.2%) | $41.20 K(-116.3%) | -$290.30 K(-21.3%) |
| May 2017 | - | -$252.00 K(+581.1%) | -$368.80 K(+175.6%) |
| Mar 2017 | - | -$37.00 K(-12.9%) | -$133.80 K(-18.9%) |
| Dec 2016 | -$164.90 K(-58.9%) | -$42.50 K(+13.9%) | -$164.90 K(+119.9%) |
| Sept 2016 | - | -$37.30 K(+119.4%) | -$75.00 K(-11.8%) |
| June 2016 | - | -$17.00 K(-75.0%) | -$85.00 K(-80.0%) |
| Mar 2016 | - | -$68.10 K(-243.7%) | -$424.30 K(+5.7%) |
| Dec 2015 | -$401.60 K(+19.7%) | $47.40 K(-200.2%) | -$401.60 K(-26.0%) |
| Sept 2015 | - | -$47.30 K(-86.7%) | -$543.00 K(-4.1%) |
| June 2015 | - | -$356.30 K(+684.8%) | -$566.40 K(+44.4%) |
| Mar 2015 | - | -$45.40 K(-51.7%) | -$392.20 K(-0.7%) |
| Dec 2014 | -$335.50 K | -$94.00 K(+33.0%) | -$394.90 K(+53.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$70.70 K(-61.2%) | -$257.90 K(+0.1%) |
| June 2014 | - | -$182.10 K(+278.6%) | -$257.60 K(-18.2%) |
| Mar 2014 | - | -$48.10 K(-211.9%) | -$315.00 K(-29.7%) |
| Dec 2013 | -$448.00 K(-54.9%) | $43.00 K(-161.1%) | -$447.80 K(-24.5%) |
| Sept 2013 | - | -$70.40 K(-70.6%) | -$593.50 K(-11.6%) |
| June 2013 | - | -$239.50 K(+32.4%) | -$671.70 K(-13.8%) |
| Mar 2013 | - | -$180.90 K(+76.1%) | -$778.80 K(-21.5%) |
| Dec 2012 | -$994.40 K(-55.3%) | -$102.70 K(-30.9%) | -$992.50 K(-23.6%) |
| Sept 2012 | - | -$148.60 K(-57.1%) | -$1.30 M(-21.4%) |
| June 2012 | - | -$346.60 K(-12.2%) | -$1.65 M(-7.5%) |
| Mar 2012 | - | -$394.60 K(-3.4%) | -$1.79 M(-19.7%) |
| Dec 2011 | -$2.22 M(-4.6%) | -$408.50 K(-18.5%) | -$2.22 M(-0.7%) |
| Sept 2011 | - | -$501.40 K(+4.2%) | -$2.24 M(+23.1%) |
| June 2011 | - | -$481.20 K(-42.1%) | -$1.82 M(-27.5%) |
| Mar 2011 | - | -$831.40 K(+96.2%) | -$2.51 M(+7.6%) |
| Dec 2010 | -$2.33 M(+17.6%) | -$423.70 K(+419.2%) | -$2.33 M(-13.4%) |
| Sept 2010 | - | -$81.60 K(-93.0%) | -$2.69 M(-15.7%) |
| June 2010 | - | -$1.17 M(+78.8%) | -$3.19 M(+36.3%) |
| Mar 2010 | - | -$654.40 K(-16.7%) | -$2.34 M(+18.2%) |
| Dec 2009 | -$1.98 M(+105.5%) | -$785.60 K(+35.0%) | -$1.98 M(+29.2%) |
| Sept 2009 | - | -$582.00 K(+82.2%) | -$1.53 M(+25.6%) |
| June 2009 | - | -$319.40 K(+9.0%) | -$1.22 M(+13.1%) |
| Mar 2009 | - | -$293.10 K(-13.4%) | -$1.08 M(+11.9%) |
| Dec 2008 | -$963.50 K(-61.2%) | -$338.60 K(+25.8%) | -$963.50 K(-34.8%) |
| Sept 2008 | - | -$269.20 K(+51.6%) | -$1.48 M(-12.8%) |
| June 2008 | - | -$177.60 K(-0.3%) | -$1.70 M(-14.8%) |
| Mar 2008 | - | -$178.10 K(-79.1%) | -$1.99 M(-20.0%) |
| Dec 2007 | -$2.49 M(+69.9%) | -$853.00 K(+75.3%) | -$2.49 M(+15.6%) |
| Sept 2007 | - | -$486.70 K(+3.3%) | -$2.15 M(-3.3%) |
| June 2007 | - | -$471.20 K(-30.2%) | -$2.22 M(+10.5%) |
| Mar 2007 | - | -$674.70 K(+30.4%) | -$2.01 M(+37.5%) |
| Dec 2006 | -$1.46 M(+37.0%) | -$517.30 K(-7.8%) | -$1.46 M(+19.5%) |
| Sept 2006 | - | -$560.80 K(+116.2%) | -$1.22 M(+56.3%) |
| June 2006 | - | -$259.40 K(+106.9%) | -$782.70 K(-18.2%) |
| Mar 2006 | - | -$125.40 K(-54.9%) | -$956.40 K(-10.4%) |
| Dec 2005 | -$1.07 M(+355.5%) | -$278.10 K(+132.1%) | -$1.07 M(+35.2%) |
| Sept 2005 | - | -$119.80 K(-72.3%) | -$789.50 K(+17.9%) |
| June 2005 | - | -$433.10 K(+83.1%) | -$669.70 K(+183.1%) |
| Mar 2005 | - | -$236.60 K | -$236.60 K |
| Dec 2004 | -$234.40 K | - | - |
FAQ
- What is Novo Integrated Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Novo Integrated Sciences?
- What is Novo Integrated Sciences annual EBIT year-on-year change?
- What is Novo Integrated Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Novo Integrated Sciences?
- What is Novo Integrated Sciences quarterly EBIT year-on-year change?
- What is Novo Integrated Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Novo Integrated Sciences?
- What is Novo Integrated Sciences TTM EBIT year-on-year change?
What is Novo Integrated Sciences annual earnings before interest & taxes?
The current annual EBIT of NVOS is -$8.15 M
What is the all time high annual EBIT for Novo Integrated Sciences?
Novo Integrated Sciences all-time high annual earnings before interest & taxes is -$11.10 K
What is Novo Integrated Sciences annual EBIT year-on-year change?
Over the past year, NVOS annual earnings before interest & taxes has changed by +$17.35 M (+68.03%)
What is Novo Integrated Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of NVOS is -$10.65 M
What is the all time high quarterly EBIT for Novo Integrated Sciences?
Novo Integrated Sciences all-time high quarterly earnings before interest & taxes is $162.30 K
What is Novo Integrated Sciences quarterly EBIT year-on-year change?
Over the past year, NVOS quarterly earnings before interest & taxes has changed by -$9.33 M (-707.23%)
What is Novo Integrated Sciences TTM earnings before interest & taxes?
The current TTM EBIT of NVOS is -$18.30 M
What is the all time high TTM EBIT for Novo Integrated Sciences?
Novo Integrated Sciences all-time high TTM earnings before interest & taxes is -$19.70 K
What is Novo Integrated Sciences TTM EBIT year-on-year change?
Over the past year, NVOS TTM earnings before interest & taxes has changed by +$7.61 M (+29.38%)